Safety Study of Nebivolol for COPD Patients
| Status: | Withdrawn |
|---|---|
| Conditions: | Chronic Obstructive Pulmonary Disease, High Blood Pressure (Hypertension), Pulmonary |
| Therapuetic Areas: | Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 40 - 75 |
| Updated: | 4/21/2016 |
| Start Date: | January 2012 |
| End Date: | March 2013 |
Nebivolol in Chronic Obstructive Pulmonary Disease
The purpose of this study is to demonstrate the safety and effectiveness of the study drug
Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary
Disease (COPD).
Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary
Disease (COPD).
The study would be a randomized, placebo-controlled trial of 60 hypertensive patients with
documented COPD greater than age 40.
documented COPD greater than age 40.
Inclusion Criteria:
- Clinical diagnosis of high blood pressure and chronic obstructive pulmonary disease
(COPD)
Exclusion Criteria:
- Asthma; Heart failur;
- End stage kidney disease;
- acute myocardial infarction,unstable angina, stroke or TIA within the past year;
- Females who are pregnant, lactating or women of childbearing potential who are not
using approved method of contraception.
We found this trial at
1
site
University of Chicago Medical Center The University of Chicago Medicine has been at the forefront...
Click here to add this to my saved trials
